SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotechnology: The Patenting of DNA

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RCMac who wrote (21)6/28/1999 11:08:00 PM
From: LLCF  Read Replies (1) of 37
 
< at some point the tool user may determine that is not worth pursuing a risky drug development project if they anticipate significant erosion of margins due to royalties,>

You know it's funny how one can whine about "royalty stacking"... If I were to form a risky venture, I would love everyone to let me use their tools for a piece of the pie instead of having to buy them or rent them with upfront money. Who are we kidding, if the things a bust no one gets a dime, just as it should be. It's all a matter of how big the royalty demanded, slam it in a spread sheet and see if the project makes sense. If not, bid the tool owner lower... if he says no, fine. It's been fat city for these guys for so long they can't see the world under their fat stomachs! By the time I retire bio's will be telling these "commodity" big pharma guys that 10% is too much just to market these new drugs.... better make it 7.5% or I'll go to LLY! This thing sells itself!

DAK
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext